Crescent Innovations, Inc. has developed a regenerative technology for joints (U.S. Patent 7,501,296).
Estimates are that as many as 30 million Americans suffer chronic pain associated with the Temporomandibular Joint (TMJ).
Extended Release Drug Delivery Technology
Crescent Innovations, Inc. has developed an extended release drug delivery technology capable of treating post surgical pain for over 24 hours with a single dose.
Degenerative Bone Conditions
Crescent Innovations, Inc. is developing a new delivery technology to help treat Degenerative Bone Conditions.